Sphingomyelinase and cell-permeable ceramide analogs increase the release of plasminogen activator inhibitor-1 from cultured endothelial cells

By Soeda S.   Honda O.   Shimeno H.   Nagamatsu A.  

Thrombosis Research, Vol. 80, Iss. 6, 1995-12 ,pp. : 509-518

Elsevier

Access to resources Recommend Favorite

The Effect of Number of Days in Culture and Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Genotype on PAI-1 Antigen Release by Cultured Human Umbilical Vein Endothelial Cells - Identification by morphologic and immunologic criteria

By McCormack L.J.   Semple J.I.   Stickland M.H.   Barrett J.H.   Grant P.J.  

Thrombosis Research, Vol. 92, Iss. 5, 1998-12 ,pp. : 199-206

Elsevier

Access to resources Recommend Favorite

Molecular Advances in Plasminogen Activator Inhibitor 1 Interaction with Thrombin and Tissue-Type Plasminogen Activator

By Stoop A.   van Meijer M.   Horrevoets A.J.G.   Pannekoek H.  

Trends in Cardiovascular Medicine, Vol. 7, Iss. 2, 1997-02 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells

By Kunieda Y.   Nakagawa K.   Nishimura H.   Kato H.   Ukimura N.   Yano S.   Kawano H.   Kimura S.   Nakagawa M.   Tsuji H.  

Thrombosis Research, Vol. 110, Iss. 4, 2003-06 ,pp. : 227-234

Elsevier

Access to resources Recommend Favorite

Urokinase binding and catabolism by Hep G2 cells is plasminogen activator inhibitor-1 dependent, analogous to interactions of tissue-type plasminogen activator with these cells

By Grimsley P.G.   Normyle J.F.   Brandt R.A.   Joulianos G.   Chesterman C.N.   Hogg P.J.   Owensby D.A.  

Thrombosis Research, Vol. 79, Iss. 4, 1995-08 ,pp. : 353-361

Elsevier

Access to resources Recommend Favorite